Edesa's pipeline is buzzing with Phase 3 wins and summit invites – real momentum. 🧪 The stock's finally responding, with today's strong close pushing the 9-period EMA above the 21. RSI just climbed out of neutral, so there's room to run. Volume confirms the move isn't a fluke. This looks like the news is finally getting priced in. BUY the story before the next catalyst. #BiotechBrewing

Edesa's Phase 3 news just lit a rocket under this stock! 📈 From oversold to a 64 RSI in days, that's a sentiment explosion. The chart shows a wild gap-up on massive volume—real conviction, not a fluke. The 9-period EMA is trying to punch through the 21, signaling momentum. This is a classic news-driven breakout. I'm calling it a BUY on the momentum, but keep a tight stop. #BiotechBreakout